Cummins, Daimler Truck, Paccar Aim to Advance U.S. Battery-Cell Production
By Colin Kellaher
Engine maker Cummins and truck makers Daimler Truck and Paccar are teaming up in an effort to advance battery-cell production and the battery supply chain in the U.S.
The companies on Wednesday said they are forming a joint venture to make battery cells for electric commercial vehicles and industrial applications, with a planned investment of $2 billion to $3 billion in a 21-gigawatt-hour factory.
Cummins, Daimler Truck and Paccar said they will each own 30% of the venture, which will initially focus on the lithium-iron-phosphate battery-technology family for commercial battery-electric trucks.
The companies said the venture will produce battery cells with lower cost and longer life compared with other battery chemistries, without the need for nickel and cobalt raw materials.
A Daimler Truck representative said the venture partners are working to find an optimal site for the planned manufacturing plant, with the announcement of a location within the next six months.
Battery-cell maker EVE Energy will serve as technology partner in the venture, with a 10% stake, the companies said.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 06, 2023 07:08 ET (11:08 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks